Xinnaoxin Tablet Study: Mouse Model Data on High-Altitude Polycythemia and Cardiac Injury

A 24.9 KB PDF document authored by Zhihui Wang and last updated on 2026-05-28 details a pharmacology study. The research investigates the mechanisms of Xinnaoxin tablets against high-altitude polycythemia and hypobaric hypoxia-induced cardiac injury in a mouse model. It likely contains results from blood parameter analysis, hemorheology, cytokine measurements, echocardiography, and Western blot analyses of signaling pathways.

Use Cases

• Analyzing drug effects on blood parameters (RBC, hemoglobin, hematocrit) and serum erythropoietin levels mentioned in the description
• Studying the modulation of inflammatory cytokines (TNF-α, IL-1β, IL-6) and oxidative stress markers (MDA, SOD, CAT) in a disease model
• Investigating coordinated changes in phosphorylation levels of MAPK, NF-κB, and PI3K/AKT signaling pathways
• Evaluating the relationship between bone marrow CD71+ cell populations and 'ineffective erythropoiesis' in polycythemia

Strengths

• The study employs a multi-level analysis strategy combining systems pharmacology with experimental validation.
• Specific methodologies like UPLC-Q-TOF-MS for metabolite identification and Western blot for protein analysis are documented.

Limitations

• The dataset is a 24.9 KB PDF, indicating it is likely a summary document or article, not raw experimental data.
• Row count and column-level documentation are absent; data structure and granularity must be inferred from the text.
• The description is detailed but does not specify the availability of underlying tabular or numerical data files.

Provenance

Source

Zhihui Wang

Collection Method

Generated from a mouse model of hypobaric hypoxia, with assessments including blood tests, echocardiography, and molecular analyses.

Freshness

Last updated 2026-05-28 04:53:01